Literature DB >> 1000436

Possible suppression of host resistance by estrogen therapy for prostatic cancer.

R J Ablin.   

Abstract

Entities:  

Keywords:  Biology; Cancer; Cytologic Effects; Diseases; Endocrine System; Estrogens--therapeutic use; Genitalia; Genitalia, Male; Hormones; Immunity; Immunological Effects; Neoplasms; Physiology; Prostate; Urogenital System

Mesh：

Substances：

Year:  1976        PMID： 1000436      PMCID： PMC1878895     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN： 0008-4409            Impact factor:   8.262


× No keyword cloud information.
  7 in total

Review 1.  Management of stage C prostatic carcinoma.

Authors:  R H Flocks; E P O'Donoghue; L A Millerman; D A Culp
Journal:  Urol Clin North Am       Date:  1975-02       Impact factor: 2.241

2.  Proceedings: Causes of death in cancer patients.

Authors:  J Inagaki; V Rodriguez; G P Bodey
Journal:  Cancer       Date:  1974-02       Impact factor: 6.860

3.  The effect of estrogen on the incorporation of 3H-thymidine by PHA-stimulated human peripheral blood lymphocytes.

Authors:  R J Ablin; G R Bruns; P Guinan; I M Bush
Journal:  J Immunol       Date:  1974-08       Impact factor: 5.422

4.  Specificity and thermodynamic properties of the corticosteroid binding to a receptor of rat thymocytes in vitro.

Authors:  B P Schaumburg; E Bojesen
Journal:  Biochim Biophys Acta       Date:  1968-11-12

5.  The autoimmune response to male reproductive tissues of rabbits. III. Effects of testosterone and estrogen on cryoimmunogenic and immunochemical expressions of the central accessory glands.

Authors:  H W Stoll; J S Ansell; M S Barnes; G W Barnes
Journal:  Invest Urol       Date:  1974-11

6.  Hormonal therapy and alteration of lymphocyte proliferation.

Authors:  R J Ablin; G R Bruns; P D Guinan; H Al sheik; I M Bush
Journal:  J Lab Clin Med       Date:  1976-02

7.  The choice of estrogen preparations in the treatment of prostatic cancer.

Authors:  A Morales; B Pujari
Journal:  Can Med Assoc J       Date:  1975-11-08       Impact factor: 8.262
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.